IBIO, INC. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-28: Form 10-K; Period of report 2026-06-30; Description 10-K; Document ibio-20260731x10k.htm.
- 2025-09-05: Form 10-K; Period of report 2025-06-30; Description 10-K; Document ibio-20250630x10k.htm.
- 2024-09-20: Form 10-K; Period of report 2024-06-30; Description 10-K; Document ibio-20240630x10k.htm.
- 2023-09-27: Form 10-K; Period of report 2023-06-30; Description 10-K; Document ibio-20230630x10k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-28 | 10-K | 2026-06-30 | 10-K | ibio-20260731x10k.htm |
| 2025-09-05 | 10-K | 2025-06-30 | 10-K | ibio-20250630x10k.htm |
| 2024-09-20 | 10-K | 2024-06-30 | 10-K | ibio-20240630x10k.htm |
| 2023-09-27 | 10-K | 2023-06-30 | 10-K | ibio-20230630x10k.htm |
| 2022-10-11 | 10-K | 2022-06-30 | 10-K | ibio-20220630x10k.htm |
| 2021-09-28 | 10-K | 2021-06-30 | 10-K | ibio-20210630x10k.htm |
| 2020-10-13 | 10-K | 2020-06-30 | FORM 10-K | tm2024769d1_10k.htm |
| 2019-08-26 | 10-K | 2019-06-30 | FORM 10-K | tv527664_10k.htm |
| 2018-09-18 | 10-K | 2018-06-30 | FORM 10-K | tv502648_10k.htm |
| 2017-09-15 | 10-K | 2017-06-30 | FORM 10-K | v474890_10k.htm |
| 2016-10-13 | 10-K | 2016-06-30 | FORM 10-K | v449304_10k.htm |
| 2015-10-13 | 10-K | 2015-06-30 | FORM 10-K | v420530_10k.htm |
| 2014-09-29 | 10-K | 2014-06-30 | FORM 10-K | v389461_10k.htm |
| 2013-09-30 | 10-K | 2013-06-30 | FORM 10-K | v355527_10k.htm |
| 2012-10-12 | 10-K | 2012-06-30 | Annual report | c71079_10-k.htm |
| 2011-09-29 | 10-K | 2011-06-30 | Annual report | c67016_10-k.htm |
| 2010-10-13 | 10-K | 2010-06-30 | Annual report | c62978_10k.htm |
| 2009-09-28 | 10-K | 2009-06-30 | Annual report | inb210k_20090928.htm |
| 2008-09-29 | 10-K | 2008-06-30 | Annual report | inb210k_20080730.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |